{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-024491","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2025-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.182747+00:00","generated_at":"2026-05-16T18:14:16.174392+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Telomir Pharmaceuticals director Craig Eagle resigns from board, effective Nov 14, 2025","bullets":["Craig Eagle resigned from the Board of Directors on November 14, 2025, effective immediately.","Resignation was not due to any disagreement with the Company, management, or other board members.","The Board thanked Mr. Eagle for his service; no successor has been announced.","Resignation letter attached as Exhibit 17.1 to the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-024491","json":"https://secwatch.observer/filing/0001493152-25-024491.json","markdown":"https://secwatch.observer/filing/0001493152-25-024491.md","text":"https://secwatch.observer/filing/0001493152-25-024491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315225024491/0001493152-25-024491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315225024491/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:14:16.174392+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}